Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review

BACKGROUND AND OBJECTIVES: Janus kinase (JAK) inhibitors are emerging as a therapeutic option for alopecia areata. The risk of potential adverse events is currently debated. In particular, several safety data for JAK inhibitors are extrapolated from a single study in elderly patients with rheumatoid...

Descripción completa

Detalles Bibliográficos
Autores principales: Papierzewska, Małgorzata, Waśkiel-Burnat, Anna, Rudnicka, Lidia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155665/
https://www.ncbi.nlm.nih.gov/pubmed/37138134
http://dx.doi.org/10.1007/s40261-023-01260-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155665/
https://www.ncbi.nlm.nih.gov/pubmed/37138134
http://dx.doi.org/10.1007/s40261-023-01260-z

Ejemplares similares